Pfizer Forecasts Flat 2026 Sales as It Builds Drug Pipeline
Pfizer Inc. forecast little growth in sales for next year as the drugmaker looks to refresh its pipeline of hit drugs with a series of pricey acquisitions.
By Madison Muller, Robert Langreth ยท Bloomberg
Pfizer Inc. forecast little growth in sales for next year as the drugmaker looks to refresh its pipeline of hit drugs with a series of pricey acquisitions.